Aspirin-Reference-Cited by-同舟云学术

Aspirin

Published:2012-03-13 Issue:10 Volume:125 Page:
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Paikin Jeremy S.¹,Eikelboom John W.¹

Affiliation:

1. From the Division of Cardiology (J.S.P.) and Department of Medicine (J.W.E.), Hamilton General Hospital, McMaster University, Hamilton, ON, Canada.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.111.046243

Reference14 articles.

1. Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs

2. Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes

3. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Wright RS;Circulation,2011

4. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

5. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physical analysis of aspirin in different phases and states using density functional theory;Heliyon;2024-06

2. Pharmacogenetics and Pharmacogenomics Impact on Aspirin Response;Pharmaceutical Science;2024-05-29

3. Inflammatory Responses in Myocardial Infarction and its Therapeutic Drugs;Drugs from Nature: Targets, Assay Systems and Leads;2024

4. The Efficacy and Safety of Antiplatelet Therapy in Patients With Acute Coronary Syndrome: A Scoping Review;Cureus;2023-11-29

5. Lipoxin and glycation in SREBP signaling: Insight into diabetic cardiomyopathy and associated lipotoxicity;Prostaglandins & Other Lipid Mediators;2023-02